|
Server : Apache/2.4.62 System : FreeBSD fbsdweb2.web.rcn.net 14.1-RELEASE FreeBSD 14.1-RELEASE releng/14.1-n267679-10e31f0946d8 GENERIC amd64 User : www ( 80) PHP Version : 8.3.8 Disable Function : NONE Directory : /domains/bluerae/clients/mipi/prototype9/molecular/ |
Upload File : |
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta name="description" content="Molecular Insight is focused on critical diagnostic and therapeutic needs of the prostate cancer patient." />
<meta name="keywords" content="prostate cancer, prostate cancer detection, prostate cancer treatment, small-molecule, radiotherapy, metastatic prostate cancer" />
<title>Molecular Insight: Targeted Radiotherapeutics</title>
<link href="../stylesmenu.css" rel="stylesheet" type="text/css" />
<link href="../styles.css" rel="stylesheet" type="text/css" />
</head>
<body>
<div id="container">
<!-- LEFT CONTAINER - CONTAINS ALL ELEMENTS ON LEFT HALF OF PAGE, EACH POSITIONED ABSOLTELY -->
<div id="leftcontainer">
<div id="logo"><a href="../index.html"><img src="../images/logo.gif" width="241" height="315" alt="Molecult Insight Home" /></a></div>
<div id="mininav"><a href="../about/contact.html">CONTACT US</a> :: <a href="../search/sitemap.html">SITEMAP</a> :: <a href="../search/index.html">SEARCH</a></div>
<div id="pagemenu">
<p class="currentsection">Molecular Medicine</p>
<ul>
<li><a href="../molecular/index.html">Overview</a></li>
<li><a href="../molecular/mip.html">Molecular Imaging <br />Pharmaceuticals</a></li>
<li><a href="../molecular/tr.html" class="current">Targeted Radiotherapeutics</a></li>
<li><a href="../molecular/pt.html">Proprietary Technologies</a></li>
</ul>
</div>
<div id="photolarge"><img src="images/p_tr.jpg" width="241" height="341" alt=" " /></div>
<div id="photosmall"> </div>
<div id="contactinfo">
<p class="address">Molecular Insight Pharmaceuticals, Inc.<br />
<a href="http://maps.google.com/maps?q=160+Second+Street,+Cambridge,+MA+02142&oe=utf-8&client=firefox-a&hnear=160+2nd+St,+Cambridge,+Massachusetts+02142&gl=us&t=m&z=16" target="_blank" class="softlink">160 Second Street, Cambridge, MA 02142</a><br />
617.492.5554 tel :: 617.492.5664 fax<br />
<a href="mailto:[email protected]">[email protected]</a><br />
</p>
</div>
</div><!--close left container-->
<!-- MAIN CONTENT - includes main menu at top -->
<div id="maincontent" >
<div id="mainmenu">
<ul>
<!--<li style="width: 400px;"> </li>-->
<li><a href="../about/index.html">About Us<span class="separator">::</span></a>
<ul>
<li><a href="../about/index.html">Overview</a></li>
<li><a href="../about/executive.html">Executive Management</a></li>
<li><a href="../about/board.html">Board of Directors</a></li>
<!-- <li><a href="../about/scientific.html">Scientific Advisory Board</a></li> -->
<li><a href="../about/careers.html">Careers</a></li>
<!-- <li><a href="../about/MolecularInsight_FactSheet.pdf">Fact Sheet (PDF)</a></li>
<li><a href="../about/video.html">Corporate Video</a></li>-->
<li><a href="../about/licensing.html">Licensing</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul>
</li>
<li><a href="../molecular/index.html" class="current">Molecular Medicine<span class="separator">::</span></a>
<ul>
<li><a href="../molecular/index.html">Overview</a></li>
<li><a href="../molecular/mip.html">Molecular Imaging <br />Pharmaceuticals</a></li>
<li><a href="../molecular/tr.html">Targeted Radiotherapeutics</a></li>
<li><a href="../molecular/pt.html">Proprietary Technologies</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul></li>
<li><a href="../pipeline/index.html">Pipeline<span class="separator">::</span></a>
<ul>
<li><a href="../pipeline/index.html">Overview</a></li>
<li><a href="../pipeline/prostate.html">Prostate Cancer</a></li>
<li><a href="../pipeline/diagnostic.html">Diagnostic</a></li>
<li><a href="../pipeline/therapeutic.html">Therapeutic</a></li>
<li><a href="../pipeline/discovery.html">Discovery</a></li>
<li><a href="../pipeline/sci_pres.html">Presentations </a></li>
<li><a href="../pipeline/sci_pub.html"> Publications</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul></li>
<li><a href="../intheclinic/index.html">In the Clinic<span class="separator">::</span></a>
<ul>
<li><a href="../intheclinic/index.html">Overview</a></li>
<img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul></li><li><a href="../media/index.html">Media Room</a>
<ul>
<li><a href="../media/index.html">Overview</a></li>
<li><a href="../media/releases.html">Press Releases</a></li>
<li><a href="../media/clips.html">Press Clips</a></li>
<img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul>
</li>
</ul>
</div>
<h1 class="pagehead"><span class="currentsection"></span>Targeted Radiotherapeutics</h1>
<p class="introtext">Radiation therapy is the medical use of ionizing radiation to <br />
treat cancer. </p>
<p>Traditional radiotherapy involves the use of focused external radiation beams that are aimed from several angles to intersect at the location of a tumor, providing a more concentrated dose of radiation at that site of disease than in the surrounding healthy tissue. Traditional radiation therapy is often used in combination with surgery, chemotherapy and/or hormone therapy. It is estimated that between 50–60% of cancer patients undergo radiation therapy during the course of their treatment. While effective for treating the primary tumor or local spread, external beam radiation may result in damage to the surrounding healthy tissue, and, importantly, is not appropriate when the cancer has metastasized to distant areas of the body.</p>
<p>The field of molecular medicine is facilitating the development of even more precise therapies through the creation of targeted radiotherapeutics. Molecular Insight is developing targeted therapeutic radiopharmaceuticals for the treatment of prostate cancer. These radiopharmaceuticals, administered systemically to a patient, consist of a homing portion of the molecule that seeks out and attaches to a cancer-restricted protein associated with the disease, enabling the delivery of the radioactive therapeutic portion of the molecule specifically to the diseased cancer cells thereby sparing the surrounding healthy tissue and organs. The ability to specifically deliver radiation to cancer cells anywhere in the body is a significant advance, allowing radiation to be applied to systemic disease.</p>
<p>Targeted therapeutic radiopharmaceuticals can be designed that are capable of delivering a variety of different radioisotopes--further enabling physicians to not only selectively target a tumor but to adjust the intensity of the radiation dose depending on the size and location of the tumor. Molecular Insight’s radiotherapeutic product candidate is <sup>131</sup>I-MIP-1095.</p>
<!-- FOOTER - contained within main content div -->
<div id="footer">
<p>Copyright © 2012 Molecular Insight. All Rights Reserved. :: <a href="../privacy.html">Privacy Policy</a> :: <a href="../terms.html">Terms of Use</a> :: <a href="../index.html"><strong>Home</strong><br />
</a>Design: <a href="http://www.bluerae.com/">Bluerae Creative</a></p>
</div>
</div>
</div><!--close container-->
<script type="text/javascript">
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-34412360-1']);
_gaq.push(['_trackPageview']);
(function() {
var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
})();
</script>
</body>
</html>